相关实验视频

Updated: Jul 10, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 12, 2013

13.7K

识别新型神经氨基酶抑制剂作为潜在的抗流感剂:虚拟查,分子对接,体外验证和分子动态模拟研究

Junya Liu1, Jinbo Niu1, Lihua Xu2

  • 1Office of Drug Clinical Trials, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Cell biochemistry and biophysics
|March 27, 2025
PubMed
概括

由于高死亡率和耐药性,迫切需要新的流感药物. 研究人员确定了E570-1769,一种新型的神经氨基酶抑制剂,显示出有前途的药用性和未来抗流感疗法的潜力.

关键词:
流感是一次流感.模拟MD的模拟方法分子对接是分子对接.神经氨基酶是什么 神经氨基酶是虚拟选是一个虚拟的选.

更多相关视频

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

20.3K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

7.0K

相关概念视频

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...